Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1
Safety Study of SLC-391 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
- Status
- TERMINATED
- Phase
- PHASE1
Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia
- Status
- UNKNOWN
- Phase
- N/A
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Trial of DFP-14927 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of ORIC-101 in Combination With Anticancer Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2